The rise in the Zydus Lifesciences shares came after the company received final approval from the United States Food and Drug ...

Zydus Lifesciences shares rose 8.34 per cent on March 19, touching an intraday high of Rs 910.30  at 1:00 PM when the company ...

Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value ...

Greater Effectiveness and Enhanced Safety Profiles of Biosimilars Compared to Their Reference Biologics Increasing Their Adoption Worldwid ...

Other PBC candidates coming through the collective industry pipeline include CymaBay's seladelpar and Zydus Cadila's saroglitazar - both PPAR agonists – as well as Genkyotex' NOX 1 and 4 ...

Several copycat versions of the drug have already been approved, including from Zydus Cadila and Lupin Labs. However, given Astellas’ plan to elevate the case to the Court of Appeals for the ...

In 1995, Cadila Laboratories and Cadila Healthcare split under the Zydus Group. After a formal separation between the two founding families, Patel took charge of Zydus Lifesciences and Cadila ...

Zydus Lifesciences rose 3% to an intra-day high of Rs 930 after the company received approval from the US FDA to manufacture ...

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture Apalutamide Tablets, 60 mg.

Zydus Lifesciences shares will be in focus on Wednesday after the company secured final approval from the US Food and Drug ...